Drug Profile
Research programme: DNA Ligase Antagonist - Ricerca
Alternative Names: Research programme: antibacterials - RicercaLatest Information Update: 30 Mar 2009
Price :
$50
*
At a glance
- Originator Ricerca Biosciences LLC
- Developer Eli Lilly and Company
- Class Small molecules
- Mechanism of Action DNA repair enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 20 Jan 2003 Preclinical trials in Bacterial infections in USA (unspecified route)